Variable | Resectable (n = 98) | Unresectable (n = 40) | P value |
---|---|---|---|
Agea | |||
 ≤60 | 46 (46.9) | 25 (62.5) | NS |
 >60 | 52 (53.1) | 15 (37.5) |  |
Gender | |||
 Female | 47 (48) | 26 (65) | NS |
 Male | 51 (52) | 14 (35) |  |
Symptom presentation | |||
 No | 38 (38.8) | 18 (45) | NS |
 Yes | 60 (61.2) | 22 (55) |  |
Preoperative hospital stay >7Â daysa | |||
 No | 62 (63.3) | 20 (52.6) | NS |
 Yes | 36 (36.7) | 18 (47.4) |  |
Preoperative CA 19-9 >200Â U/mlb | |||
 No | 82 (83.7) | 8 (20) | <0.001 |
 Yes | 16 (16.3) | 32 (80) |  |
Preoperative CA 125 >26Â U/mlb | |||
 No | 77 (78.6) | 13 (32.5) | <0.001 |
 Yes | 21 (21.4) | 27 (67.5) |  |
Preoperative CEA >3.4Â ng/mlb | |||
 No | 59 (60.2) | 22 (55) | NS |
 Yes | 39 (39.8) | 18 (45) |  |
Preoperative ALT level >50Â U/lc | |||
 No | 25 (25.5) | 16 (40) | NS |
 Yes | 73 (74.5) | 24 (60) |  |
Preoperative AST level >40Â U/lc | |||
 No | 21 (21.4) | 11 (27.5) | NS |
 Yes | 77 (78.6) | 29 (72.5) |  |
Preoperative albumin level >40Â g/lc | |||
 No | 63 (64.3) | 20 (50) | NS |
 Yes | 35 (35.7) | 20 (50) |  |
Tumor sized | |||
 ≤3 cm | 76 (77.6) | 18 (45) | <0.001 |
 >3 cm | 22 (22.4) | 22 (55) |  |
BMIa | |||
 ≤21 kg/m2 | 66 (67.3) | 19 (47.5) | 0.03 |
 >21 kg/m2 | 32 (32.7) | 21 (52.5) |  |
Bismuth–Corlette classification | |||
 I and II | 61 (62.2) | 16 (40) | 0.017 |
 III and IV | 37 (37.8) | 24 (60) |  |